Details of the Drug

General Information of Drug (ID: DMT10TD)

Drug Name

BIVV-003

Indication

Disease Entry	ICD 11	Status	REF
Sickle-cell disorder	3A51	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03653247) A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease (PRECIZN-1). U.S. National Institutes of Health.